The Use of Real-world Data to Generate Real-world Evidence to Accelerate Neonatal Drug Development
- 2 December 2024
- journal article
- editorial
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
- Vol. 37 (1) , 110-113
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Effect of Early vs Late Inguinal Hernia Repair on Serious Adverse Event Rates in Preterm InfantsJAMA, 2024
- Use of Dexmedetomidine and Opioids in Hospitalized Preterm InfantsJAMA Network Open, 2023
- Real-World Evidence for Neonatal Drug Development: Challenges and OpportunitiesThe Journal of Pediatrics, 2023
- Applications of artificial intelligence in drug development using real-world dataDrug Discovery Today, 2020
- Explainable artificial intelligence models using real-world electronic health record data: a systematic scoping reviewJournal of the American Medical Informatics Association, 2020
- Bronchopulmonary dysplasiaNature Reviews Disease Primers, 2019
- Sharing Data to Accelerate Medicine Development and Improve Neonatal Care: Data Standards and Harmonized DefinitionsThe Journal of Pediatrics, 2018
- The International Neonatal Consortium: collaborating to advance regulatory science for neonatesPediatric Research, 2016
- Global Collaboration to Develop New and Existing Drugs for NeonatesJAMA Pediatrics, 2015
- Serum creatinine concentration in very-low-birth-weight infants from birth to 34–36 wk postmenstrual agePediatric Research, 2015